Cargando…
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
BACKGROUND: Previous studies have revealed the role of dysregulated urokinase plasminogen activator (encoded by PLAU) expression and activity in several pathways associated with cancer progression. However, systematic investigation into the association of PLAU expression with factors that modulate P...
Autores principales: | Hosen, S. M. Zahid, Uddin, Md. Nazim, Xu, Zhihong, Buckley, Benjamin J., Perera, Chamini, Pang, Tony C. Y., Mekapogu, Alpha Raj, Moni, Mohammad Ali, Notta, Faiyaz, Gallinger, Steven, Pirola, Ron, Wilson, Jeremy, Ranson, Marie, Goldstein, David, Apte, Minoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794594/ https://www.ncbi.nlm.nih.gov/pubmed/36591282 http://dx.doi.org/10.3389/fimmu.2022.1060957 |
Ejemplares similares
-
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Xu, Zhihong, et al.
Publicado: (2020) -
Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)
por: Wang, Yanyan, et al.
Publicado: (2021) -
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
por: Kumar, Ashna A., et al.
Publicado: (2022) -
Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis
por: Perera, Chamini J., et al.
Publicado: (2021) -
Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes
por: Binang, Helen B., et al.
Publicado: (2023)